Latest Insider Transactions at Talaris Therapeutics, Inc. (TALS)
This section provides a real-time view of insider transactions for Talaris Therapeutics, Inc. (TALS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Talaris Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Talaris Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2024
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Indirect |
1,779
+20.26%
|
$24,906
$14.85 P/Share
|
|
Aug 16
2024
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Indirect |
5,221
+50.0%
|
$67,873
$13.79 P/Share
|
|
Jan 29
2024
|
Mark Mcdade Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+18.23%
|
$3,200,000
$32.5 P/Share
|
|
Nov 17
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+0.55%
|
$64,000
$16.99 P/Share
|
|
Nov 17
2023
|
Parvinder Thiara Director |
BUY
Open market or private purchase
|
Direct |
1,000
+1.18%
|
$17,000
$17.31 P/Share
|
|
Oct 27
2023
|
Caley Castelein Director |
BUY
Open market or private purchase
|
Direct |
15,800
+2.97%
|
$221,200
$14.55 P/Share
|
|
Oct 26
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.68%
|
$60,000
$12.25 P/Share
|
|
Oct 25
2023
|
Caley Castelein Director |
BUY
Open market or private purchase
|
Direct |
4,200
+0.83%
|
$50,400
$12.07 P/Share
|
|
Oct 25
2023
|
Parvinder Thiara Director |
BUY
Open market or private purchase
|
Direct |
2,000
+2.36%
|
$24,000
$12.12 P/Share
|
|
Oct 24
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Direct |
4,650
+0.64%
|
$46,500
$10.68 P/Share
|
|
Oct 24
2023
|
Aaron Kantoff Director |
BUY
Open market or private purchase
|
Direct |
7,500
+14.18%
|
$82,500
$11.86 P/Share
|
|
Oct 24
2023
|
Parvinder Thiara Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.83%
|
$50,000
$10.66 P/Share
|
|
Oct 19
2023
|
Sapna Srivastava Director |
BUY
Grant, award, or other acquisition
|
Direct |
518
+50.0%
|
-
|
|
Oct 19
2023
|
Parvinder Thiara Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,782
+50.0%
|
-
|
|
Oct 19
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Grant, award, or other acquisition
|
Direct |
716,085
+50.0%
|
-
|
|
Oct 19
2023
|
Mark Mcdade Director |
BUY
Grant, award, or other acquisition
|
Direct |
518
+50.0%
|
-
|
|
Oct 19
2023
|
Mark Mcdade Director |
BUY
Grant, award, or other acquisition
|
Indirect |
348,431
+50.0%
|
-
|
|
Oct 19
2023
|
W Bradford Middlekauff CBO, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
69,201
+50.0%
|
-
|
|
Oct 19
2023
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Indirect |
458,039
+50.0%
|
-
|
|
Oct 19
2023
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
496,519
+50.0%
|
-
|
|
Oct 19
2023
|
Yung H. Chyung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,836
+50.0%
|
-
|
|
Oct 19
2023
|
Kevin Bruce Johnson Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,834
+50.0%
|
-
|
|
Oct 19
2023
|
Susan Dana Jones Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,934
+50.0%
|
-
|
|
Oct 19
2023
|
Aaron Kantoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,891
+50.0%
|
-
|
|
Jul 03
2023
|
Mary Kay Fenton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,946
-15.98%
|
$38,838
$3.08 P/Share
|
|
Jul 03
2023
|
Scott Requadt |
SELL
Payment of exercise price or tax liability
|
Direct |
11,786
-2.0%
|
$35,358
$3.08 P/Share
|
|
Jun 14
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
12,942
-0.34%
|
$25,884
$2.49 P/Share
|
|
Jun 13
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
14,208
-0.37%
|
$28,416
$2.56 P/Share
|
|
Jun 12
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
16,870
-0.44%
|
$33,740
$2.59 P/Share
|
|
Jun 09
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
25,419
-0.66%
|
$50,838
$2.46 P/Share
|
|
Jun 08
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
40,642
-1.05%
|
$81,284
$2.48 P/Share
|
|
Jun 07
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
75,001
-1.9%
|
$150,002
$2.39 P/Share
|
|
Jun 06
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
25,549
-0.92%
|
$51,098
$2.53 P/Share
|
|
Jun 05
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
7,841
-0.28%
|
$15,682
$2.52 P/Share
|
|
Jun 02
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
15,818
-0.56%
|
$31,636
$2.5 P/Share
|
|
Jun 01
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
15,713
-0.56%
|
$31,426
$2.56 P/Share
|
|
Apr 21
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
15,004
-0.53%
|
$30,008
$2.35 P/Share
|
|
Apr 20
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
46,990
-1.63%
|
$93,980
$2.33 P/Share
|
|
Apr 19
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
21,753
-0.75%
|
$43,506
$2.16 P/Share
|
|
Apr 18
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
49,211
-1.67%
|
$98,422
$2.15 P/Share
|
|
Apr 17
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
99,771
-3.27%
|
$199,542
$2.14 P/Share
|
|
Mar 17
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
10,436
-0.34%
|
$20,872
$2.06 P/Share
|
|
Mar 03
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
6,806
-0.22%
|
$13,612
$2.06 P/Share
|
|
Mar 01
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
29
-0.0%
|
$58
$2.05 P/Share
|
|
Feb 21
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
3,500
-0.11%
|
$7,000
$2.05 P/Share
|
|
Feb 17
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
3,612
-0.12%
|
$7,224
$2.05 P/Share
|
|
Feb 16
2023
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
2,939
-0.1%
|
$5,878
$2.06 P/Share
|
|
Dec 30
2022
|
Scott Requadt |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.0%
|
$0
$0.87 P/Share
|
|
Sep 10
2022
|
Michael Zdanowski Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+49.7%
|
-
|
|
Sep 10
2022
|
Scott Requadt |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+11.94%
|
-
|